| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/05/2005 | US6914075 Cystine derivative and agent for suppressing activation of inflammatory factors |
| 07/05/2005 | US6914074 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer |
| 07/05/2005 | US6914059 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/05/2005 | US6913900 Plasma prekallikrein activation and kallikrein production assay |
| 07/05/2005 | CA2230082C Amide compounds and use thereof |
| 07/05/2005 | CA2199679C Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients |
| 07/05/2005 | CA2165446C Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 06/30/2005 | WO2005058875A1 Piperazine triazine compounds, preparation thereof and pharmaceutical compositions |
| 06/30/2005 | WO2005058338A1 Use of an extract of aloysia/verbena/lippia triphylla/citriodora for treating chronic and/or inflammatory diseases |
| 06/30/2005 | WO2005058336A1 Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 06/30/2005 | WO2005034952A3 Isoxazole and isothiazole compounds useful in the treatment of inflammation |
| 06/30/2005 | WO2005025574A3 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
| 06/30/2005 | WO2003064629A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2005 | US20050143583 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 06/30/2005 | US20050143578 Compounds and methods |
| 06/30/2005 | US20050143470 therapeutic treatment of Porcine Respiratory Disease Complex (PRDC) in pigs and Bovine Respiratory Syndrome (BRS) in calves; oral treatment; veterinary medicine |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143430 Catechol bioisosteres |
| 06/30/2005 | US20050143408 Aporphine esters and their use in therapy |
| 06/30/2005 | US20050143391 Heterocyclic amides with alpha-4 integrin antagonist activity |
| 06/30/2005 | US20050143390 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/30/2005 | US20050143379 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 06/30/2005 | US20050143368 Chemical compounds |
| 06/30/2005 | US20050143346 Blocks the phosphorylation of ceramide and sphingosine, thereby maintaining high concentration of ceramide and sphingosine; has inhibitory activity of sphingosine kinase |
| 06/30/2005 | US20050143324 Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye |
| 06/30/2005 | US20050143307 Biological activity that prevents the binding of formyl methionine-leucine-phenylalanine (fMLP) and/or C5a protein to granulocytes; acute and chronic inflammation reactions and HIV infection |
| 06/30/2005 | US20050143302 Inhibiting NF-kappa B-dependent target gene expression in a cell; fusions of a NEMO binding domain and a membrane translocation domain (third helix of antennapedia homeodomain or the HIV-1 Tat protein) |
| 06/30/2005 | US20050142535 Ogligonucleotides comprising alternating segments and uses thereof |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | US20050142138 Endothelial cell expression patterns |
| 06/30/2005 | US20050142110 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta; free of human serum albumin; stability |
| 06/30/2005 | US20050142101 Chemically modified peptides derived from the chemokine CCL14 (HCC-1) can be used; replacement of the ultimate N-terminal amino acid of CCL14[9-74] by nonanoic acid (NNY) converts it into a potent agonist; inactivation of the chemokine receptor; antiinflammatory agents |
| 06/30/2005 | US20050142072 Drug delivery into nose; controlling concentration into blood; using opioid or non-steroil antiinflammatory dryg |
| 06/30/2005 | CA2580663A1 Use of an extract of aloysia/verbena/lippia triphylla/citriodora for treating chronic and/or inflammatory diseases |
| 06/30/2005 | CA2557004A1 Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
| 06/30/2005 | CA2549662A1 A method for the production of enriched hop extracts having combined oestrogenic and antiproliferative bioactivity |
| 06/30/2005 | CA2549303A1 Novel sodium channel |
| 06/30/2005 | CA2547633A1 Hydronopol derivatives as agonists on human orl1 receptors |
| 06/29/2005 | EP1548121A1 Novel physiologically active substances |
| 06/29/2005 | EP1548032A1 Kdr peptides and vaccines comprising the same |
| 06/29/2005 | EP1548029A2 Peptid- and peptide mimetic derivatives having integrin inhibitor properties III |
| 06/29/2005 | EP1548015A1 Novel crystals |
| 06/29/2005 | EP1548003A1 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 06/29/2005 | EP1547615A1 Remedy |
| 06/29/2005 | EP1547597A2 Use of adatanserin for the treatment of neurodegenerative conditions |
| 06/29/2005 | EP1547595A1 Patch for transdermal administration |
| 06/29/2005 | EP1547587A1 Agent for reducing side effects of diclofenac |
| 06/29/2005 | EP1547586A1 Hypogastric and/or perineal pain-relieving agent |
| 06/29/2005 | EP1547585A1 Therapeutic agent for rheumatism containing benzamide derivative as active ingredient |
| 06/29/2005 | EP1546377A2 Methods and compositions to treat pain and painful disorders using 9949, 14230, 760, 62553, 41897, 47174, 33408, 10002,16209, 314, 636, 27410, 33260, 619,15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 9569 or 13424 molecules |
| 06/29/2005 | EP1546375A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 06/29/2005 | EP1546173A2 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 06/29/2005 | EP1546167A1 Compounds that interact with kinases |
| 06/29/2005 | EP1546130A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 06/29/2005 | EP1546128A1 Pyrimidine derivatives as selective cox-2 inhibitors |
| 06/29/2005 | EP1546117A2 Protein kinase inhibitors and uses thereof |
| 06/29/2005 | EP1546116A1 Vanilloid receptor ligands and their use in treatments |
| 06/29/2005 | EP1546107A1 Cox-2 inhibiting pyridine derivatives |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1546087A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 06/29/2005 | EP1546084A1 2,4-dihydroxybenzoic acid derivatives |
| 06/29/2005 | EP1545710A2 Therapeutic use |
| 06/29/2005 | EP1545620A1 Pharmaceutical compositions comprising cyclosporin for oral administration |
| 06/29/2005 | EP1545602A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 06/29/2005 | EP1545589A1 A method of modulating endothelial cell activity |
| 06/29/2005 | EP1545572A2 Conjugates activated by cell surface proteases and therapeutic uses thereof |
| 06/29/2005 | EP1545555A2 Compositions and methods for treating epithelial and retinal tissue diseases |
| 06/29/2005 | EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 06/29/2005 | EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS |
| 06/29/2005 | EP1545522A1 Use of vanilloid receptor antagonists for the treatment of pain |
| 06/29/2005 | EP1432686B1 Tetrahydroisochinolines, their production and the use thereof as analgesics |
| 06/29/2005 | EP1343786B1 Novel pyridine-substituted pyrazolopyridine derivatives |
| 06/29/2005 | EP1315727B1 7-oxo pyridopyrimidines |
| 06/29/2005 | EP1274701B1 [1,4']-bipiperidine compounds |
| 06/29/2005 | EP1272507B1 Integrin binding peptide derivatives |
| 06/29/2005 | EP0721501B1 Pharmaceutical composition comprising phosphatase or a derivative thereof |
| 06/29/2005 | CN1633444A 6-11 bicyclic ketolide derivatives |
| 06/29/2005 | CN1633440A Derivatives of branched-chain lipophilic molecules and uses thereof |
| 06/29/2005 | CN1633436A Pyrrolopyrimidine derivatives |
| 06/29/2005 | CN1633429A 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives |
| 06/29/2005 | CN1633428A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 06/29/2005 | CN1633418A Arylalkane-sulfonamides having endothelin-antagonist activity |
| 06/29/2005 | CN1633416A Nicotinamide derivates useful as p38 inhibitors |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/29/2005 | CN1633308A Treatment of ophthalmic disorders using urea and urea derivatives |
| 06/29/2005 | CN1633306A Viral inhibition by n-docosanol |
| 06/29/2005 | CN1633305A Pharmaceutical compositions based on anticholinergics and additional active ingredients |
| 06/29/2005 | CN1633299A Estrogen replacement therapy |
| 06/29/2005 | CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1633294A 2, 4, 5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 06/29/2005 | CN1633290A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 06/29/2005 | CN1633284A Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/29/2005 | CN1633282A Orodispersible effervescent tablets |
| 06/29/2005 | CN1633281A Intraorally disintegrating valdecoxib compositions |
| 06/29/2005 | CN1632119A Human LSB gene sequence, encoded polypeptide thereof, preparation method and use therefor |
| 06/29/2005 | CN1631898A Mitochondria traffic protein molecule for human marrow stromal cell and sequence encoding same and use thereof |